integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
WLMHJNWKLOYTGX-JFIUGZSTSA-N
WLMHJNWKLOYTGX-JFIUGZSTSA-N
WLMHJNWKLOYTGX-JFIUGZSTSA-N
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
WLMHJNWKLOYTGX-JFIUGZSTSA-N
InChI Key
WLMHJNWKLOYTGX-JFIUGZSTSA-N
IUPAC name
Preferred name
WLMHJNWKLOYTGX-JFIUGZSTSA-N
INN name
—
Synonym
—
ChEBI
—
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
Observed in differential profiles
Normal_control_no_tumor_vs_FH_deficient_RCC
Control_12h_vs_Toxocara canis_12h